Background Advances in diagnostic and therapeutic strategies in oncology have
significantly increased the chance of survival of cancer patients, even those with metastatic …

Survivors of early-stage breast cancer may report treatment-related side effects that persist
for several years after the end of primary treatment. Among these, fatigue and cognitive …

Observational data have shown that some cancer survivors develop chronic conditions like
frailty, sarcopenia, cardiac dysfunction, and mild cognitive impairment earlier and/or at a …

Cancer is primarily a disease of aging, and the majority of new diagnoses of cancer occur in
patients $65 years of age (herein referred to as older). 1 At the same time, cancer and its …

Background Cancer and its treatments may accelerate aging in survivors; however, research
has not examined epigenetic markers of aging in longer term breast cancer survivors. This …

Background Cognitive impairment has a great negative impact on quality of life for breast
cancer survivors. Emerging evidence suggested that physical exercise can improve …

Background Increasing attention has been dedicated to investigate modifiable risk factors of
late effects in survivors of childhood cancer. This study aims to evaluate neurocognitive and …

This scoping review was designed to synthesize the extant literature on associations
between subjective and/or objective measures of cancer-related cognitive impairment …

Chemotherapy-induced cognitive impairment (CICI) is often reported as a neurotoxic side
effect of chemotherapy. Although CICI has emerged as a significant medical problem …

Background Chemo‐and radiotherapy for breast cancer (BC) can lead to cardiotoxicity even
years after the initial treatment. The pathophysiology behind these late cardiac effects is …